TrialJAMA2023

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Jun Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.